Clinical Trials Directory

Trials / Completed

CompletedNCT01932281

SierraSil Joint Formula 14 as an Ergogenic Aid to Performance in Athletes

SierraSil as an Ergogenic Aid to Performance in Athletes

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
10 (actual)
Sponsor
University of British Columbia · Academic / Other
Sex
Male
Age
19 Years – 35 Years
Healthy volunteers
Accepted

Summary

The purpose of this study is to examine whether supplementation with SierraSil can improve anaerobic power and reduce muscle fatigue in a group of well-trained athletes. A secondary purpose is to examine the effect of SierraSil on the severity of delayed onset muscle soreness.

Detailed description

This is a double blind, crossover, pilot study that will examine the effect of SierraSil supplementation on the determinants of human performance. Anaerobic capacity, muscle fatigue, the severity of delayed onset muscle soreness (DOMS) and markers of inflammation will be measured before and after 3 weeks of supplementation with SierraSil or placebo. There will be a 3 week washout period prior to the crossover to ensure SierraSil supplementation has no residual effect.

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENTSierraSilSierraSil is a natural, mineral supplement currently used to improve joint health and function.
DIETARY_SUPPLEMENTPlaceboSugar pill manufactured to mimic SierraSil 667 mg capsule

Timeline

Start date
2014-05-01
Primary completion
2014-09-01
Completion
2014-09-01
First posted
2013-08-30
Last updated
2015-07-15

Locations

1 site across 1 country: Canada

Source: ClinicalTrials.gov record NCT01932281. Inclusion in this directory is not an endorsement.